Unknown

Dataset Information

0

Synthesis of α-Ketoamide-Based Stereoselective Calpain-1 Inhibitors as Neuroprotective Agents.


ABSTRACT: Calpain inhibitors have been proposed as drug candidates for neurodegenerative disorders, with ABT-957 entering clinical trials for Alzheimer's disease and mild cognitive impairment. The structure of ABT-957 was very recently disclosed, and trials were terminated owing to inadequate CNS concentrations to obtain a pharmacodynamic effect. The multistep synthesis of an α-ketoamide peptidomimetic inhibitor series potentially including ABT-957 was optimized to yield diastereomerically pure compounds that are potent and selective for calpain-1 over papain and cathepsins B and K. As the final oxidation step, with its optimized synthesis protocol, does not alter the configuration of the substrate, the synthesis of the diastereomeric pair (R)-1-benzyl-N-((S)-4-((4-fluorobenzyl)amino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide (1 c) and (R)-1-benzyl-N-((R)-4-((4-fluorobenzyl)amino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide (1 g) was feasible. This allowed the exploration of stereoselective inhibition of calpain-1, with 1 c (IC50 =78 nM) being significantly more potent than 1 g. Moreover, inhibitor 1 c restored cognitive function in amnestic mice.

SUBMITTER: Jastaniah A 

PROVIDER: S-EPMC8583780 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2844255 | biostudies-literature
| S-EPMC2631982 | biostudies-literature
| S-EPMC10675174 | biostudies-literature
| S-EPMC1388272 | biostudies-literature
| S-EPMC4021159 | biostudies-literature
| S-EPMC6595966 | biostudies-literature
| S-EPMC5890317 | biostudies-literature
2023-11-14 | GSE247565 | GEO
| S-EPMC5260052 | biostudies-literature
| S-EPMC2852025 | biostudies-literature